Relay Therapeutics, Inc. (RLAY)
12.09
-0.11
(-0.90%)
USD |
NASDAQ |
May 18, 16:00
12.09
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Research and Development Expense (Quarterly) : 70.56M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 33.33M |
| Spyre Therapeutics, Inc. | 60.41M |
| Revolution Medicines, Inc. | 341.62M |
| Tango Therapeutics, Inc. | 33.07M |
| Summit Therapeutics, Inc. | 132.62M |